1. Home
  2. VRDN vs TCBK Comparison

VRDN vs TCBK Comparison

Compare VRDN & TCBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • TCBK
  • Stock Information
  • Founded
  • VRDN 2006
  • TCBK 1975
  • Country
  • VRDN United States
  • TCBK United States
  • Employees
  • VRDN N/A
  • TCBK N/A
  • Industry
  • VRDN Medical Specialities
  • TCBK Major Banks
  • Sector
  • VRDN Health Care
  • TCBK Finance
  • Exchange
  • VRDN Nasdaq
  • TCBK Nasdaq
  • Market Cap
  • VRDN 1.6B
  • TCBK 1.5B
  • IPO Year
  • VRDN N/A
  • TCBK N/A
  • Fundamental
  • Price
  • VRDN $16.27
  • TCBK $44.05
  • Analyst Decision
  • VRDN Buy
  • TCBK Hold
  • Analyst Count
  • VRDN 12
  • TCBK 5
  • Target Price
  • VRDN $36.44
  • TCBK $50.75
  • AVG Volume (30 Days)
  • VRDN 979.5K
  • TCBK 94.9K
  • Earning Date
  • VRDN 03-04-2025
  • TCBK 01-23-2025
  • Dividend Yield
  • VRDN N/A
  • TCBK 3.00%
  • EPS Growth
  • VRDN N/A
  • TCBK N/A
  • EPS
  • VRDN N/A
  • TCBK 3.46
  • Revenue
  • VRDN $302,000.00
  • TCBK $389,190,000.00
  • Revenue This Year
  • VRDN $3.30
  • TCBK N/A
  • Revenue Next Year
  • VRDN N/A
  • TCBK $5.63
  • P/E Ratio
  • VRDN N/A
  • TCBK $12.73
  • Revenue Growth
  • VRDN N/A
  • TCBK N/A
  • 52 Week Low
  • VRDN $11.40
  • TCBK $31.73
  • 52 Week High
  • VRDN $27.20
  • TCBK $51.06
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 36.43
  • TCBK 48.02
  • Support Level
  • VRDN $15.62
  • TCBK $43.90
  • Resistance Level
  • VRDN $18.15
  • TCBK $45.07
  • Average True Range (ATR)
  • VRDN 0.91
  • TCBK 1.05
  • MACD
  • VRDN -0.20
  • TCBK 0.03
  • Stochastic Oscillator
  • VRDN 14.48
  • TCBK 42.68

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of Treasury Management Services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

Share on Social Networks: